GLORIA

GEOMAR Library Ocean Research Information Access

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 2015-2019  (16)
  • 1985-1989  (13)
Document type
Keywords
Language
Years
Year
  • 1
    Online Resource
    Online Resource
    Cham :Springer International Publishing AG,
    Keywords: Drug interactions. ; Electronic books.
    Type of Medium: Online Resource
    Pages: 1 online resource (307 pages)
    Edition: 1st ed.
    ISBN: 9783319342115
    Series Statement: Cancer Drug Discovery and Development Series
    DDC: 611.01816
    Language: English
    Note: Intro -- Foreword -- Preface -- Acknowledgments -- Contents -- Editors and Contributors -- Introduction -- 1 PI3K-Akt-mTOR Signaling in Cancer and Cancer Therapeutics -- Introduction -- The PI3K-Akt-mTOR Signaling Pathway -- PI3K-Akt-mTOR Signaling in Human Physiology: Anabolic Metabolism -- PI3K-Akt-mTOR Signaling in Human Physiology: Regulation of Cell Cycle Progression and Survival -- PI3K-Akt-mTOR in Human Disease: Germline Disorders of Overgrowth and Cancer Susceptibility -- PI3K-Akt-mTOR in Human Disease: Somatic Genetic Mutations in Syndromes of Segmental Overgrowth and Cancer -- Targeting Oncogenic PI3K-Akt-mTOR Signaling for Cancer Therapy -- Clinical Responses to PI3K-Akt-mTOR Inhibitors -- Putative Mechanisms Underlying Suboptimal Drug Responses: Incomplete Pathway Suppression -- Putative Mechanisms Underlying Suboptimal Drug Responses: PI3K Inhibitors Cause Hyperglycemia and Hyperinsulinemia -- Putative Mechanisms Underlying Suboptimal Drug Responses: Drug-Induced Signaling Adaptation and Feedback -- Future Directions: Identifying Effective Drug Combinations -- Conclusion -- Acknowledgments -- References -- Part I PI3K-mTOR Pathway in Cancers -- 2 The mTOR Complexes in Cancer Cell Metabolism -- Introduction -- Glucose Metabolism (Glycolysis) -- Oxidative and Mitochondrial Metabolism -- Glutamine Metabolism -- Amino Acid Metabolism -- Pentose Phosphate Pathway and Nucleotide Synthesis -- Lipid Metabolism -- Acetylation -- Clinical Relevance -- Conclusions and Future Perspectives -- Acknowledgments -- References -- 3 PI3K-AKT-mTOR Pathway Cooperates with the DNA Damage Repair Pathway: Carcinogenesis in Triple-Negative Breast Cancers and Beyond -- Introduction -- Alterations of PI3K-AKT-mTOR Pathway in BC -- Alterations of PI3K-AKT-mTOR Pathway in Subtypes of BC -- Alteration(S) of PI3K-AKT-mTOR Pathway in BC Is Contextual. , PI3K-AKT-mTOR Pathway Alterations in the Context of DNA Damage Response -- DNA Damage in Invasive Carcinoma of Breast: Alterations of DDR Pathway Genes and HRD Genes in Basal-Like BC -- PI3K-AKT-mTOR Pathway and DDR Pathway in Basal-like BC: Protein-Protein Interactions -- 17 PI3K-AKT-mTOR Signaling Pathway Genes: Proteins (Amino Acid -- Aa) and Their Cellular Functions -- 12 DNA Damage Repair Pathway Genes: Proteins and Their Cellular Functions -- PI3K-AKT-mTOR Pathway Inhibition in the Context of DDR: PARP Inhibitors in BC -- PARP Inhibitors as Chemo/Radiopotentiating Agents: TNBC and Beyond -- A Combination of PARP Inhibitors and PI3K-AKT-mTOR Pathway Inhibitors: Drug Sensitivity and Drug Resistance -- Acknowledgments -- References -- 4 The AKT-mTOR Signaling Pathway for Drug Response Prediction and Prognostic Signatures -- The PI3K-AKT-mTOR Signaling Pathway in Cancer: An Overview -- The PI3K-AKT-mTOR Pathway: Kinase Activation and Signaling Cascades -- The PI3K-AKT-mTOR Pathway: Association Between PIK3CA Mutation and Activation of the PI3K-AKT-mTOR Signaling Network -- Activation of the PI3K-AKT-mTOR Signaling Pathway as Prognostic and Predictive Biomarker -- High Throughput Multiplexed Platforms for Functional Analysis of the PI3K-AKT-mTOR Pathway of Clinical Samples -- Antibody-Based Technologies -- Multiplex Immunoassays -- Reverse Phase Protein Microarray -- Phosphoflow -- Tissue Microarrays -- Non-antibody-Based Technologies -- Concluding Remarks -- References -- 5 Resistance to PI3K Pathway Inhibition -- Introduction -- The PI3K-AKT-mTOR Pathway -- Drug-Induced Relief of Feedback Results in Pathway Reactivation -- mTORC1 Inhibition Promotes AKT Activation -- mTORC1 Inhibition Relieves GRB10-Mediated PI3K Suppression -- mTOR Kinase Inhibition Causes Feedback-Dependent Biphasic Regulation of AKT Signaling. , AKT Feedback Regulation of RTK Expression -- Drug-Induced Adaptive/Compensatory Activation of Parallel Signaling Pathways in the Network -- Activation of ERK Signaling -- Coordinated Activation of RAS/RAF Signaling in Resistance -- Feedback Regulation of Nuclear Hormone Signaling -- Wnt-β-Catenin Cooperation with PI3K Signaling -- Myc Amplification -- JAK2/STAT5 Inhibition Circumvents PI3K Resistance -- Additional Implicated Mechanisms of PI3K Resistance, Mechanisms not yet Elucidated -- mTORC1 Inhibition Is Required for Sensitivity to PI3K-Alpha Inhibition -- Inactivating PTEN Mutations Result in PI3K-Beta Hyperactivation -- Mechanisms of Resistance Common to Cellular Signaling Pathways -- Ligand-Mediated Activation of Distinct, Non-inhibited Kinases with Shared Downstream Targets -- Tumor Microenvironment May Confer Targeted Therapy Resistance -- Drug-Resistance-Conferring Oncogene Alterations -- Conclusion and Future Directions -- References -- Part II PI3K-mTOR Pathway in Cancer Medicine -- 6 Combination Therapies Targeting the PI3K/AKT/mTOR Pathways -- Introduction -- Positive Regulators of PI3K/AKT/mTOR Pathways -- PI3K -- Agents Targeting PI3K Isoforms -- AKT -- Agents Targeting AKT -- mTOR Complex -- Agents Targeting mTORC1 -- Dual Kinase Inhibitors -- Negative Regulators of PI3K/AKT/mTOR Pathways -- PTEN -- Tuberous Sclerosis Complex (TSC) and the TSC1-TSC2 Complex -- AMPK -- Toxicity of PI3K/AKT/mTOR Inhibitors -- PI3K/AKT/mTOR Combination Strategies -- PI3K/AKT/mTOR Inhibitor and Chemotherapy -- PI3K/AKT/mTOR Inhibitor and Hormonal Agents -- PI3K/AKT/mTOR Inhibitor and Immunotherapy -- PI3K/AKT/mTOR Inhibitor and Biological Therapy -- Proximal/Distal Inhibition (mTOR Inhibitor and IGF Receptor [IGFR], PI3K, or AKT Inhibitor) -- Parallel Signaling Inhibition -- PI3K/AKT/mTOR Inhibitor and Other Targeted Therapies -- Triple Combinations. , Biomarkers -- Conclusion -- References -- 7 Phospho-Inositol-3-Kinase Activity and Dysregulation in Pediatric Leukemia and Lymphoma -- Introduction -- Phosphatidylinositol-3-Kinase (PI3K)-AKT-mTOR Signaling -- PI3K and Cancer -- The Catalytic Subunit p110δ as a Potential Target in Hematologic Malignancies -- Acute Lymphoblastic Leukemia (ALL) -- Lymphoma -- Acute Myeloid Leukemia (AML) -- Chronic Myeloid Leukemia (CML) -- Juvenile Myelomonocytic Leukemia (JMML) -- Clinical Trials -- Conclusions -- Review Criteria -- Acknowledgements -- References -- 8 HER2 Signaling Network in Advanced Breast Cancer: Opportunities for Combination Therapies -- Background -- The PI3K-AKT-mTOR Pathway in HER2 Positive Breast Cancer -- An Overview of the Pathway -- Involvement of the PI3K Pathway HER2+ Breast Cancer -- Activation of PTEN-PI3K-AKT-mTOR Pathway and Anti-HER2 Therapy Resistance -- PI3K-AKT-mTOR Pathway-Specific Inhibitors Either Approve or Active in Clinical Trial -- Pan HER Inhibitors in HER2+ Breast Cancer -- Conclusion -- Acknowledgments -- References -- 9 The PI3K-mTOR Pathway in Prostate Cancer: Biological Significance and Therapeutic Opportunities -- Introduction -- PI3K-mTOR Signaling and Function -- PI3K-mTOR Signaling in Prostate Cancer -- The PI3K-mTOR Pathway and Epigenetic Programming in Prostate Cancer Pathogenesis -- Crosstalk with AR and Other Signaling in Castration-Resistant Prostate Cancer -- The PI3K-mTOR Pathway in Prostate Cancer Metastasis -- Targeting the PI3K-mTOR Pathway in Prostate Cancer -- PI3K Inhibitors -- AKT Inhibitors -- mTOR Inhibitors -- Dual PI3K-mTOR Inhibitors -- Future Perspectives -- References -- Index.
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Havertown :Pen & Sword Books Limited,
    Keywords: Astronomy. ; Electronic books.
    Type of Medium: Online Resource
    Pages: 1 online resource (481 pages)
    Edition: 1st ed.
    ISBN: 9781526753281
    DDC: 520.5
    Language: English
    Note: Intro -- Title -- Copyright -- Contents -- Editor's Foreword -- Preface -- About Time -- Using the Yearbook of Astronomy as an Observing Guide -- The Monthly Star Charts -- Northern Hemisphere Star Charts David Harper -- Southern Hemisphere Star Charts David Harper -- The Planets in 2020 Lynne Marie Stockman -- Phases of the Moon in 2020 -- Eclipses in 2020 -- Some Events in 2020 -- Monthly Sky Notes and Articles 2020 -- January -- Dark Sky Places: Now and in the Future Bob Mizon -- February -- Ashes to Ashes, Stardust to Stardust Peter Rea -- March -- Pre-Iron Age Uses of Meteorites Carolyn Kennett -- April -- The Revd Doctor William Pearson Mike Frost -- May -- Astronomy Stamps Martin Beech -- June -- Cometary Comedy and Chaos Courtney Seligman -- July -- A Pair of Classic Doubles in Cygnus John McCue -- August -- Proper Motion Martin Whipp -- September -- A Closer Look at Indus Brian Jones -- October -- Airbursts: A Spectacular Astronomical Phenomenon Susan Stubbs -- November -- Toads, Earthworms and Slugs Among the Stars David Harper 155 -- December -- Jupiter and Saturn David Harper -- Comets in 2020 Neil Norman -- Minor Planets in 2020 Neil Norman -- Meteor Showers in 2020 Neil Norman -- Article Section -- Astronomy in 2019 Rod Hine -- Solar System Exploration in 2019 Peter Rea -- Anniversaries in 2020 Neil Haggath -- 200 Years of the Royal Astronomical Society Sian Prosser -- The Naming of Stars David Harper -- Astronomical Sketching Steve Brown -- Dark Matter and Galaxies Julian Onions -- Eclipsing Binaries Tracie Heywood -- A Perspective on the Aboriginal View of the World Greg Quicke -- The First Known Black Hole David M. Harland -- 'Oumuamua - Interstellar Interloper Neil Norman -- Forgotten on the Moon Bill Leatherbarrow -- Miscellaneous -- Some Interesting Variable Stars Roger Pickard -- Some Interesting Double Stars Brian Jones. , Some Interesting Nebulae, Star Clusters and Galaxies Brian Jones -- Astronomical Organizations -- Our Contributors -- Glossary Brian Jones and David Harper.
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    Havertown :Pen & Sword Books Limited,
    Keywords: Astronomy. ; Electronic books.
    Type of Medium: Online Resource
    Pages: 1 online resource (374 pages)
    Edition: 1st ed.
    ISBN: 9781526737069
    DDC: 520.5
    Language: English
    Note: Intro -- Title -- Copyright -- Contents -- Editor's Foreword -- Preface -- About Time -- Using the Yearbook of Astronomy as an Observing Guide -- The Monthly Star Charts -- Northern Hemisphere Star Charts David Harper -- Southern Hemisphere Star Charts David Harper -- The Planets in 2019 Lynne Marie Stockman -- Phases of the Moon in 2019 -- Eclipses in 2019 -- Some Events in 2019 -- Monthly Sky Notes and Articles 2019 -- January -- A Closer Look at Lepus Brian Jones -- February -- ICON Explores the Ionosphere Richard Pearson -- March -- A Closer Look at Sextans Brian Jones -- April -- Movable Feasts and Leaping Moons David Harper -- May -- When Astronomy Meets the Law David Harper -- June -- Lunar Occultations and Conjunctions in 2019 Richard Pearson -- July -- Georges Henri Joseph Édouard Lemaître David M. Harland -- August -- First Light for Gravitational Waves Richard Pearson -- September -- Humboldt and the Gegenschein Richard Pearson -- October -- A Closer Look at Equuleus Brian Jones -- November -- The Transit of Mercury Richard Pearson -- December -- William Frederick Denning Richard Pearson -- Comets in 2019 Neil Norman -- Minor Planets in 2019 Neil Norman -- Meteor Showers in 2019 Neil Norman -- Article Section -- Astronomy in 2018 Rod Hine -- Solar System Exploration in 2018 Peter Rea -- Anniversaries in 2019 Neil Haggath -- The Cassini-Huygens Mission to the Saturn System Carl Murray -- Science Fiction and the Future of Astronomy Mike Brotherton -- Asaph Hall: Man of Mars Neil Norman -- Getting the Measure of Double Stars John McCue -- 100 Years of the International Astronomical Union Susan Stubbs -- In Total Support of Einstein: Eddington's Eclipse, 1919 Neil Haggath -- The First Micro-Quasar David M. Harland -- Father Lucian Kemble and the Kemble Asterisms Steve Brown -- Mira 'The Wonderful' Roger Pickard -- Miscellaneous. , Some Interesting Variable Stars to Observe in 2019 Roger Pickard -- Some Interesting Double Stars Brian Jones -- Some Interesting Nebulae, Star Clusters and Galaxies Brian Jones -- Astronomical Organizations -- Our Contributors -- Glossary Brian Jones and David Harper.
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    New York :Pen & Sword Books Limited,
    Keywords: Astronomy. ; Electronic books.
    Type of Medium: Online Resource
    Pages: 1 online resource (303 pages)
    Edition: 1st ed.
    ISBN: 9781526717436
    Language: English
    Note: Intro -- Title -- Copyright -- Contents -- Editors’ Foreword -- Preface -- About Time -- Using the Yearbook of Astronomy as an Observing Guide -- The Monthly Star Charts -- Northern Hemisphere Star Charts -- Southern Hemisphere Star Charts -- Phases of the Moon in 2018 -- Eclipses in 2018 -- Monthly Sky Notes and Articles 2018 -- January -- The Double Blue Moon of 2018 David Harper -- February -- The James Webb Space Telescope Richard Pearson -- March -- A Closer Look at Antlia and Pyxis Brian Jones -- April -- Fate or Destiny Richard Pearson -- May -- The Royal Greenwich Observatory Richard Pearson -- June -- A Closer Look at Corona Borealis Brian Jones -- July -- Mars at Opposition Richard Pearson -- August -- Life on the Moon Richard Pearson -- September -- A Closer Look at Sculptor Brian Jones -- October -- Mission to Mercury: BepiColombo Richard Pearson -- November -- Edmond Halley: A Question of Pronunciation Brian Jones -- December -- Gaia and the Distances of the Stars Richard Pearson -- Comets in 2018 Neil Norman -- Minor Planets in 2018 Neil Norman -- Meteor Showers in 2018 Neil Norman -- Article Section -- Astronomy in 2017 Rod Hine -- Solar System Exploration in 2017 Peter Rea -- Anniversaries in 2018 Neil Haggath -- Comets and How to Photograph Them Damian Peach -- Double and Multiple Stars John McCue -- Some Pioneering Lady Astronomers Mike Frost -- Is There Still a Place for Art in Astronomy? David A Hardy -- Supermassive Black Holes David M Harland -- Modern Video Astronomy Steve Wainwright -- Miscellaneous -- Some Interesting Variable Stars Roger Pickard -- Some Interesting Double Stars Brian Jones -- Some Interesting Nebulae, Star Clusters and Galaxies Brian Jones -- Astronomical Organizations -- Our Contributors -- Glossary Brian Jones.
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Electronic Resource
    Electronic Resource
    s.l. : American Chemical Society
    Journal of the American Chemical Society 109 (1987), S. 4780-4786 
    ISSN: 1520-5126
    Source: ACS Legacy Archives
    Topics: Chemistry and Pharmacology
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Publishing Ltd
    Sedimentology 36 (1989), S. 0 
    ISSN: 1365-3091
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Geosciences
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    ISSN: 1432-0843
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary Flavone acetic acid (FAA) is a synthetic flavonoid compound which has recently begun clinical trials as an antitumor agent based on its striking activity in solid tumor model systems. The pharmacologic behavior of FAA in animals appears to be predictive of both its cytotoxic efficacy and its toxicity to normal tissues (principally the central nervous system and gastrointestinal tract). The design and conduct of phase I studies in man are based upon these principles, with the goal of maximizing their safety and efficacy.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Electronic Resource
    Electronic Resource
    Springer
    Cancer chemotherapy and pharmacology 18 (1986), S. 185-197 
    ISSN: 1432-0843
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    Electronic Resource
    Electronic Resource
    Springer
    Cancer chemotherapy and pharmacology 19 (1987), S. 350-350 
    ISSN: 1432-0843
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    ISSN: 1573-0646
    Keywords: Echinomycin ; intercalator ; Quinomycin A
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Summary Echinomycin is a quinoxaline antibiotic that was originally isolated from Streptomyces echinatus. Based on its antitumor activity against two i.p. implanted murine tumors, the B16 melanoma, and the P388 leukemia, it was brought into clinical trials by the National Cancer Institute. Recent studies on its cytotoxic action have related its antitumor activity with its ability to bifunctionally intercalate with double stranded DNA. Toxicologic studies were carried out in CDF1 mice and beagle dogs using intravenous injections. For the mice studies the dose ranges were 288–692 mcg/kg (864–2076 mcg/m2) by single bolus, and 112–254 mcg/kg/day (336–762 mcg/m2/day) for five consecutive days. In the dog, dose ranges studied were 8.9–89.4 mcg/kg (178–1788 mcg/m2) by single bolus, and 3.4–33.5 mcg/kg/day (68–670 mcg/m2/day) for five consecutive days. The major toxic effects were found in the gastrointestinal, hepatic, and lymphoreticular systems. These were reversible at all but the highest dose, in dogs that had been treated for five consecutive days. Phase I clinical trials using various intravenous schedules were sponsored by the National Cancer Institute. Nausea, vomiting, reversible liver enzyme abnormalities, and allergic reactions were the most common toxicities encountered. Based on results from these studies, the National Cancer Institute has recently begun phase II trials in a broad range of diseases. These trials will further characterize echinomycin's toxic effects and its antitumor activity.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...